NCT06803212Completed
Investigation of Dual-Task Exercise's Effect in Parkinson's Disease
Effect of Dual-Task Interference on Upper Extremity Motor Experience With Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 31 Jan 2025
Brief summary (registry, in English)
This study was conducted to investigate the effects of dual-task training on upper extremity motor functions in patients with Parkinson's disease. A total of 32 patients participated in the study. Patients were divided into two groups by randomization. One group received only conventional physiotherapy applications, while the other group performed dual-task exercises in addition. Dual-task exercises were performed while conventional treatment was applied. The treatment program was applied as 60x5x6 min/day/week. Conventional treatment was determined according to the individual needs of the patients, including the lower and upper extremities. Dual-task interventions included performing such as counting backward, word recall, and reading words backward. Assessments were repeated twice: Baseline and after a 30-session. "Demographic Information", "Movement Disorder Society (MDS)-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)", "Box and Block Test" and "Parkinson Disease Questionnaire (PDQ-39) were used as assessment tools.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 32 (actual)
- First submitted
- 27 Jan 2025
- Start date
- 28 Jun 2024
- Primary completion date
- 30 Dec 2024
- Lead sponsor
- Emre Şenocak
- Diseases
- Parkinson disease
- NCT number
- NCT06803212
What you commit to
- Study type: Interventional
- Participants enrolled: 32
- From 28 Jun 2024 to the primary completion date, 30 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Having deep brain stimulator implants, or sensory loss in the upper extremities.
Other
- Patients with vision or hearing impairments,
- Moderate-to-severe fluctuations in tremor or dyskinesia,
Who the study is looking for
- Patients aged 50-85 years with a diagnosis of Stage 1-3 Parkinson's disease, based on the Hoehn \& Yahr Scale
- Patients had to have no issues with performing basic mathematical operations, - A Mini-Mental State Examination (MMSE) score above 24 points,
- Regular medication use for at least 4 weeks (for patients who were prescribed medical treatment),
- No comorbid neurological, neuromuscular, or orthopedic diseases
Age in the registry: 50 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| İstanbul Tıp Merkezi Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.